Results 291 to 300 of about 1,857,510 (308)

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

Application and Analysis of Target Cost Management in Enterprise Economic Management

Academic Journal of Business & Management, 2022
openaire   +1 more source

Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors

Ca-A Cancer Journal for Clinicians, 2011
Kiran K Turaga
exaly  

Issues with implementing a high‐quality lung cancer screening program

Ca-A Cancer Journal for Clinicians, 2014
James L Mulshine
exaly  

Recent Progress in the Management of Advanced Renal Cell Carcinoma

Ca-A Cancer Journal for Clinicians, 2007
Brian I Rini
exaly  

Patient‐centered, evidence‐based, and cost‐conscious cancer care across the continuum: Translating the Institute of Medicine report into clinical practice

Ca-A Cancer Journal for Clinicians, 2014
Larissa Nekhlyudov, Arti Hurria
exaly  

Progress and controversies: Radiation therapy for prostate cancer

Ca-A Cancer Journal for Clinicians, 2014
Neil E Martin
exaly  

Angiogenesis Inhibitors: Current Strategies and Future Prospects

Ca-A Cancer Journal for Clinicians, 2010
Kristina M Cook, William D Figg
exaly  

Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association

Ca-A Cancer Journal for Clinicians, 2004
Robert A Smith
exaly  

Targeting Apoptosis Pathways in Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2005
exaly